Melanoma Clinical Trials in Seattle

Showing 121-124 of 124 trials

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

NCT00095108

This study is being done to see if an experimental drug called recombinant interleukin-21 (rIL-21) when given to patients with stage 4 malignant melanoma or stage 4 kidney cancer is safe and has any effect on these types of cancers.

MelanomaKidney NeoplasmsMetastases

ZymoGenetics43 participantsStarted May 2004

Ann Arbor, Michigan, United States • Seattle, Washington, United States

COMPLETEDPhase 3< 1 mile

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Injecting allovectin-7 into a person's melanoma cells may make the body build an immune response that will kill tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or without immunotherapy in treating patients who have stage III or stage IV melanoma.

Stage IV MelanomaStage III MelanomaRecurrent Melanoma

VicalStarted Jul 1998

Little Rock, Arkansas, United States • Bakersfield, California, United States • Encinitas, California, United States +41 more locations

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma Trials in Other Cities

Vaccine Therapy for Patients With Stage IV Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Other Conditions in Seattle